{"id":431,"date":"2014-06-25T11:56:09","date_gmt":"2014-06-25T09:56:09","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/"},"modified":"2026-10-06T06:55:25","modified_gmt":"2026-10-06T03:55:25","slug":"asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/","title":{"rendered":"ASV farm\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam &#8220;Shire&#8221;"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<div class=\"new_item_title\">Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums &#8220;Shire Pharmaceuticals&#8221; noraid\u012bjusi neofici\u0101lu ASV konkurenta &#8220;AbbVie&#8221; izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis &#8220;AbbVie&#8221;.<\/div>\n<p>&#8220;AbbVie&#8221; nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu &#8220;Shire&#8221; akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju, zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA.<\/p>\n<p>&#8220;Shire&#8221; piektdien pazi\u0146ojis, ka jaun\u0101kais &#8220;AbbVie&#8221; pied\u0101v\u0101jums noraid\u012bts, jo tas uz\u0146\u0113mumu nov\u0113rt\u0113jis p\u0101r\u0101k zemu.<\/p>\n<p>www.farmacija-mic.lv<\/p>\n<p><a href=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/LETA_logo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-1785\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/LETA_logo.jpg\" alt=\"LETA_logo\" width=\"202\" height=\"84\"><\/a><\/p>\n<p><em>Foto &#8211; sciencecarriers.sciencemag.com<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums &#8220;Shire Pharmaceuticals&#8221; noraid\u012bjusi neofici\u0101lu ASV konkurenta &#8220;AbbVie&#8221; izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis &#8220;AbbVie&#8221;. &#8220;AbbVie&#8221; nor\u0101d\u012bjis, ka tre\u0161\u0101 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":22289,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[9,70,76],"tags":[],"mic_flag":[],"class_list":["post-431","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-arzemes","category-farmacijas-zinas","category-jaunakie-raksti"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums &quot;Shire Pharmaceuticals&quot; noraid\u012bjusi neofici\u0101lu ASV konkurenta &quot;AbbVie&quot; izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis &quot;AbbVie&quot;.&quot;AbbVie&quot; nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu &quot;Shire&quot; akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju,\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"ASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums &quot;Shire Pharmaceuticals&quot; noraid\u012bjusi neofici\u0101lu ASV konkurenta &quot;AbbVie&quot; izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis &quot;AbbVie&quot;.&quot;AbbVie&quot; nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu &quot;Shire&quot; akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju,\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-06-25T09:56:09+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:55:25+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"ASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums &quot;Shire Pharmaceuticals&quot; noraid\u012bjusi neofici\u0101lu ASV konkurenta &quot;AbbVie&quot; izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis &quot;AbbVie&quot;.&quot;AbbVie&quot; nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu &quot;Shire&quot; akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju,\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/#listItem\",\"name\":\"\\u0100rzem\\u0113s\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/#listItem\",\"position\":2,\"name\":\"\\u0100rzem\\u0113s\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#listItem\",\"name\":\"ASV farm\\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu konkurentam &#8220;Shire&#8221;\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#listItem\",\"position\":3,\"name\":\"ASV farm\\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu konkurentam &#8220;Shire&#8221;\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/#listItem\",\"name\":\"\\u0100rzem\\u0113s\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#newsarticle\",\"name\":\"ASV farm\\u0101cijas gigants \\u201cAbbVie\\u201d izteicis p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu konkurentam \\u201cShire\\u201d - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"ASV farm\\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu konkurentam &#8220;Shire&#8221;\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/AbbVie-Sign-Photo.jpg\",\"width\":300,\"height\":300},\"datePublished\":\"2014-06-25T11:56:09+03:00\",\"dateModified\":\"2026-10-06T06:55:25+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#webpage\"},\"articleSection\":\"\\u0100rzem\\u0113s, Farm\\u0101cija, Jaun\\u0101kie raksti\",\"dateline\":\"Published on June 25, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/\",\"name\":\"ASV farm\\u0101cijas gigants \\u201cAbbVie\\u201d izteicis p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu konkurentam \\u201cShire\\u201d - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Londonas bir\\u017e\\u0101 kot\\u0113tais farm\\u0101cijas uz\\u0146\\u0113mums \\\"Shire Pharmaceuticals\\\" noraid\\u012bjusi neofici\\u0101lu ASV konkurenta \\\"AbbVie\\\" izteiktu p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu 27 miljardu sterli\\u0146u m\\u0101rci\\u0146u (33,7 miljardu eiro) apm\\u0113r\\u0101, piektdien pazi\\u0146ojis \\\"AbbVie\\\".\\\"AbbVie\\\" nor\\u0101d\\u012bjis, ka tre\\u0161\\u0101 un jaun\\u0101k\\u0101 pied\\u0101v\\u0101juma v\\u0113rt\\u012bba veidoja 46,26 m\\u0101rci\\u0146as par vienu \\\"Shire\\\" akciju. ASV uz\\u0146\\u0113mums pirmo pied\\u0101v\\u0101jumu izteicis maija s\\u0101kum\\u0101, t\\u0101 v\\u0113rt\\u012bbai veidojot 39,5 m\\u0101rci\\u0146as par vienu akciju,\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/AbbVie-Sign-Photo.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#mainImage\",\"width\":300,\"height\":300},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\\\/#mainImage\"},\"datePublished\":\"2014-06-25T11:56:09+03:00\",\"dateModified\":\"2026-10-06T06:55:25+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"ASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d - Medikamentu Inform\u0101cijas Centrs","description":"Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums \"Shire Pharmaceuticals\" noraid\u012bjusi neofici\u0101lu ASV konkurenta \"AbbVie\" izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis \"AbbVie\".\"AbbVie\" nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu \"Shire\" akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju,","canonical_url":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/arzemes\/#listItem","name":"\u0100rzem\u0113s"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/arzemes\/#listItem","position":2,"name":"\u0100rzem\u0113s","item":"https:\/\/farmacija-mic.lv\/category\/arzemes\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#listItem","name":"ASV farm\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam &#8220;Shire&#8221;"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#listItem","position":3,"name":"ASV farm\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam &#8220;Shire&#8221;","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/arzemes\/#listItem","name":"\u0100rzem\u0113s"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#newsarticle","name":"ASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d - Medikamentu Inform\u0101cijas Centrs","headline":"ASV farm\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam &#8220;Shire&#8221;","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg","width":300,"height":300},"datePublished":"2014-06-25T11:56:09+03:00","dateModified":"2026-10-06T06:55:25+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#webpage"},"articleSection":"\u0100rzem\u0113s, Farm\u0101cija, Jaun\u0101kie raksti","dateline":"Published on June 25, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/","name":"ASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d - Medikamentu Inform\u0101cijas Centrs","description":"Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums \"Shire Pharmaceuticals\" noraid\u012bjusi neofici\u0101lu ASV konkurenta \"AbbVie\" izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis \"AbbVie\".\"AbbVie\" nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu \"Shire\" akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju,","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#mainImage","width":300,"height":300},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/#mainImage"},"datePublished":"2014-06-25T11:56:09+03:00","dateModified":"2026-10-06T06:55:25+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"ASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d - Medikamentu Inform\u0101cijas Centrs","og:description":"Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums &quot;Shire Pharmaceuticals&quot; noraid\u012bjusi neofici\u0101lu ASV konkurenta &quot;AbbVie&quot; izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis &quot;AbbVie&quot;.&quot;AbbVie&quot; nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu &quot;Shire&quot; akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju,","og:url":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg","og:image:width":300,"og:image:height":300,"article:published_time":"2014-06-25T09:56:09+00:00","article:modified_time":"2026-10-06T03:55:25+00:00","twitter:card":"summary_large_image","twitter:title":"ASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Londonas bir\u017e\u0101 kot\u0113tais farm\u0101cijas uz\u0146\u0113mums &quot;Shire Pharmaceuticals&quot; noraid\u012bjusi neofici\u0101lu ASV konkurenta &quot;AbbVie&quot; izteiktu p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu 27 miljardu sterli\u0146u m\u0101rci\u0146u (33,7 miljardu eiro) apm\u0113r\u0101, piektdien pazi\u0146ojis &quot;AbbVie&quot;.&quot;AbbVie&quot; nor\u0101d\u012bjis, ka tre\u0161\u0101 un jaun\u0101k\u0101 pied\u0101v\u0101juma v\u0113rt\u012bba veidoja 46,26 m\u0101rci\u0146as par vienu &quot;Shire&quot; akciju. ASV uz\u0146\u0113mums pirmo pied\u0101v\u0101jumu izteicis maija s\u0101kum\u0101, t\u0101 v\u0113rt\u012bbai veidojot 39,5 m\u0101rci\u0146as par vienu akciju,","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/AbbVie-Sign-Photo.jpg"},"aioseo_meta_data":{"post_id":"431","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-23 01:23:51","updated":"2026-10-07 12:05:18"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/arzemes\/\" title=\"\u0100rzem\u0113s\">\u0100rzem\u0113s<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tASV farm\u0101cijas gigants \u201cAbbVie\u201d izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam \u201cShire\u201d\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"\u0100rzem\u0113s","link":"https:\/\/farmacija-mic.lv\/category\/arzemes\/"},{"label":"ASV farm\u0101cijas gigants &#8220;AbbVie&#8221; izteicis p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu konkurentam &#8220;Shire&#8221;","link":"https:\/\/farmacija-mic.lv\/en\/asv-farmacijas-gigants-abbvie-izteicis-parnemsanas-piedavajumu-konkurentam-shire\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=431"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/431\/revisions"}],"predecessor-version":[{"id":2162,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/431\/revisions\/2162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/22289"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=431"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}